Literature DB >> 3127094

Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.

A Millward1, M J Hussain, M Peakman, D A Pyke, R D Leslie, D Vergani.   

Abstract

Using an indirect immunofluorescence technique we have investigated the titre, immunoglobulin class, complement-fixing ability, light chain type and IgG subclass of islet cell antibodies (ICA) in the sera of 21 recently diagnosed insulin-dependent diabetics and four non-diabetics before they developed diabetes. In the recently diagnosed patients titres of ICA ranged from 1/10 to 1/640. ICA belonged to the IgG class in all cases and fixed complement in 14 (67%). In all patients tested both kappa and lambda light chains were found, indicating that the antibody is polyclonal. IgG subclasses of ICA were investigated using specific murine monoclonal antibodies. All patients had ICA of the IgG1 subclass and in 16 (76%) this was the only subclass detected. In the remainder, one or more of the other IgG subclasses were found in association with IgG1. In the four pre-diabetic patients ICA fixed complement, was polyclonal and in all cases was of the IgG1 subclass. These characteristics of ICA, therefore, precede the onset of diabetes. The titre of ICA in the pre-diabetics tended to be greater (range 1/320 to (1/1280) than in the recently diagnosed diabetics. These results demonstrate restriction of ICA to the IgG1 subclass.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127094      PMCID: PMC1541437     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

2.  Monoclonal antibodies (McAbs) to determinants on human gamma chains: properties of antibodies showing subclass restriction or subclass specificity.

Authors:  J Lowe; P Bird; D Hardie; R Jefferis; N R Ling
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

3.  IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases.

Authors:  M Zouali; R Jefferis; A Eyquem
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

4.  Predominance of IgG3 subclass in primary cirrhosis.

Authors:  O Riggione; R P Stokes; R A Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-26

5.  IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability.

Authors:  B M Dean; G F Bottazzo; A G Cudworth
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

6.  The IgG subclass responses of human lymphocytes to B-cell activators.

Authors:  L Walker; G D Johnson; I C MacLennan
Journal:  Immunology       Date:  1983-10       Impact factor: 7.397

7.  Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.

Authors:  G J Bruining; J Molenaar; C W Tuk; J Lindeman; H A Bruining; B Marner
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

8.  Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus.

Authors:  K Buschard; S Madsbad; J Rygaard
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

9.  Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.

Authors:  M Peakman; A Lobo-Yeo; G Mieli-Vergani; E T Davies; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

10.  Islet-cell antibodies in diabetes mellitus.

Authors:  R Lendrum; G Walker; A G Cudworth; C Theophanides; D A Pyke; A Bloom; D R Gamble
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321

View more
  5 in total

1.  The effects of islet cell surface antibodies on the metabolic function of mouse islet B cells in vitro.

Authors:  D M Dronfield; M Peakman; K W Taylor
Journal:  Acta Diabetol       Date:  1995-10       Impact factor: 4.280

2.  A new antigen recognized by anti-liver-kidney-microsome antibody (LKMA).

Authors:  P Codońer-Franch; K Paradis; M Gueguen; O Bernard; A A Costesec; F Alvarez
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.

Authors:  M Peakman; T Warnock; A Vats; G L McNab; J Underhill; P T Donaldson; D Vergani
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

4.  Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M M Zanone; M Peakman; T Purewal; P J Watkins; D Vergani
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

5.  Association of stiff-person syndrome with autoimmune endocrine diseases.

Authors:  Yi-Yin Lee; I-Wen Chen; Szu-Tah Chen; Chih-Ching Wang
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.